MedTrace Logo

Personalized Feedback for Smokers With Elevated Anxiety Sensitivity

NCT03382093 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 95

Last updated 2019-06-19

No results posted yet for this study

Summary

This project will develop and refine a computer-delivered integrated Personalized Feedback Intervention (PFI) that directly addresses smoking and anxiety sensitivity (AS). The PFI will focus on feedback about smoking behavior, AS, and adaptive coping strategies.

Conditions

  • Anxiety Disorders
  • Anxiety
  • Tobacco Dependence
  • Smoking, Cigarette
  • Smoking, Tobacco

Interventions

BEHAVIORAL

Personalized Feedback Intervention

Personalized Feedback Intervention for smoking and anxiety.

BEHAVIORAL

Smoking Information Control

Smoking Information with no personalized feedback.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • University of Houston

    lead OTHER

Principal Investigators

  • Lorra L. Garey, MA · University of Houston

  • Michael J. Zvolensky, PHD · University of Houston

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-23
Primary Completion
2019-06-01
Completion
2019-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03382093 on ClinicalTrials.gov